LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT WITH ASET THERAPEUTICS, LLC (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Nov. 25, 2014	Aug. 31, 2015
Other income		$ 150,000
Proceeds from note receivable		50,000
Increase in note receivable		$ 100,000
Costs and Expenses [Member]
Reimbursement revenue	$ 150,000
Research and Development Expense [Member]
Reimbursement revenue	75,000
Maximum [Member] | Costs and Expenses [Member]
Reimbursement revenue	50,000
Licensing Agreements [Member]
Investment amount received	250,000
Reimbursement revenue	75,000
Investment required by company	1,000,000
Licensing Agreements [Member] | Minimum [Member]
Investment amount received	$ 1,250,000
Equity ownership	20.00%